Sandbox: malabsorption: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 5: | Line 5: | ||
{| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | ||
! rowspan="4 | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause | ||
| colspan=" | | colspan="9" |'''Clinical manifestation''' | ||
! colspan=" | ! colspan="5" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Lab findings | ||
! rowspan="4 | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Extra intestinal findings | ||
! rowspan="4 | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause/Pathogenesis | ||
! rowspan="4 | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard diagnosis | ||
|- | |- | ||
! colspan=" | ! colspan="8" |Symptoms | ||
! rowspan="3 | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Signs | ||
|- | |- | ||
! colspan=" | ! colspan="2" |Duration | ||
! rowspan="2 | ! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diarrhea | ||
! rowspan="2 | ! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | ||
! rowspan="2 | ! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal pain | ||
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | |||
! | ! | ||
|- | |- | ||
! | !Acute | ||
!Chronic | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Watery | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Bloody | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fatty | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |WBC | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Hgb | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Plt | |||
!S/E | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other lab findings | |||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Whipple's disease]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 44: | Line 50: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓/↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓/↑ | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Hypoalbuminemia]] | *[[Hypoalbuminemia]] | ||
Line 61: | Line 68: | ||
* [[PCR]] testing | * [[PCR]] testing | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Celiac disease]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 75: | Line 84: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[IgA]] endomysial antibody | * [[IgA]] endomysial antibody | ||
Line 94: | Line 104: | ||
* [[IgA]] tissue transglutaminase antibody | * [[IgA]] tissue transglutaminase antibody | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Tropical sprue]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 109: | Line 121: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Vitamin B12 deficiency|Low vitamin B12]] | * [[Vitamin B12 deficiency|Low vitamin B12]] | ||
Line 120: | Line 133: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Crohns disease]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 134: | Line 149: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Iron deficiency]] | * [[Iron deficiency]] | ||
Line 146: | Line 162: | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Ulcerative colitis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 163: | Line 181: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Hypoalbuminemia | * Hypoalbuminemia | ||
Line 180: | Line 199: | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Cystic fibrosis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 194: | Line 215: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Positive [[DNA]] analysis for [[CFTR]] | * Positive [[DNA]] analysis for [[CFTR]] | ||
Line 206: | Line 228: | ||
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | * Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[VIPoma]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 222: | Line 246: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Elevated [[VIP]] level | *Elevated [[VIP]] level | ||
Line 239: | Line 264: | ||
* Followed by imaging | * Followed by imaging | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Zollinger-Ellison syndrome]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 251: | Line 278: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Positive [[secretin]] stimulation test | * Positive [[secretin]] stimulation test | ||
Line 261: | Line 289: | ||
* Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL | * Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Eosinophilic gastroenteritis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 273: | Line 303: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Elevated [[serum]] [[IgE]] levels | * Elevated [[serum]] [[IgE]] levels | ||
Line 286: | Line 317: | ||
* [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | * [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Primary bile acid malabsorption]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 298: | Line 331: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Low [[Vitamin A|vitamins A]], [[Vitamin D|D]], E, and K | * Low [[Vitamin A|vitamins A]], [[Vitamin D|D]], E, and K | ||
Line 308: | Line 342: | ||
* Positive [[SeHCAT]] | * Positive [[SeHCAT]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Abetalipoproteinemia]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 322: | Line 358: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Low [[triglyceride]] | * Low [[triglyceride]] | ||
Line 335: | Line 372: | ||
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level | * Clinical findings and low [[triglyceride]] and [[cholesterol]] level | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Microscopic colitis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 347: | Line 386: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Elevated [[autoantibodies]] include: | * Elevated [[autoantibodies]] include: | ||
Line 366: | Line 406: | ||
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Hyperthyroidism]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 381: | Line 423: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Elevated [[T4]] | * Elevated [[T4]] | ||
Line 396: | Line 439: | ||
* [[TSH]] | * [[TSH]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Lactose intolerance]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 411: | Line 456: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Hydrogen breath test]] | * [[Hydrogen breath test]] | ||
Line 423: | Line 469: | ||
* [[Lactase]] activity assay | * [[Lactase]] activity assay | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Irritable bowel syndrome]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 437: | Line 485: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 443: | Line 492: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Chronic pancreatitis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 454: | Line 505: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 460: | Line 512: | ||
* [[Secretin]] stimulation test | * [[Secretin]] stimulation test | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Cirrhosis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 471: | Line 525: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 476: | Line 531: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Short bowel syndrome]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 487: | Line 544: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 492: | Line 550: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |Intestinal [[lymphoma]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 503: | Line 563: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 508: | Line 569: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Agammaglobulinemia]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 519: | Line 582: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 524: | Line 588: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |Intestinal [[lymphangiectasia]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 535: | Line 601: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 540: | Line 607: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Amyloidosis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 551: | Line 620: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 556: | Line 626: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Mastocytosis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 567: | Line 639: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 572: | Line 645: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Small intestinal bacterial overgrowth]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 583: | Line 658: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 588: | Line 664: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |Drug induced [[enteritis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 599: | Line 677: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 604: | Line 683: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[HIV AIDS|HIV infection]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 615: | Line 696: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 620: | Line 702: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Giardiasis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 631: | Line 715: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 636: | Line 721: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Strongyloidiasis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 647: | Line 734: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 652: | Line 740: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Tuberculosis]] | ||
| | |||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 663: | Line 753: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 677: | Line 768: | ||
{| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | ||
! rowspan="4 | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause | ||
| colspan="7 | | colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestation''' | ||
! colspan="4" rowspan="3 | ! colspan="4" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Lab findings | ||
! rowspan="4 | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | ||
! rowspan="4 | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause/Pathogenesis | ||
! rowspan="4 | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard diagnosis | ||
|- | |- | ||
! colspan="6 | ! colspan="6" style="background:#4479BA; color: #FFFFFF;" align="center" |Symptoms | ||
! rowspan="3 | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Signs | ||
|- | |- | ||
! colspan="3 | ! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diarrhea | ||
! rowspan="2 | ! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | ||
! rowspan="2 | ! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal pain | ||
! rowspan="2 | ! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | ||
! | ! | ||
|- | |- | ||
! | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Watery | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Bloody | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fatty | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |WBC | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Hgb | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Plt | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other lab findings | |||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Whipple's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 733: | Line 824: | ||
* [[PCR]] testing | * [[PCR]] testing | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Celiac disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 766: | Line 857: | ||
* [[IgA]] tissue transglutaminase antibody | * [[IgA]] tissue transglutaminase antibody | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Tropical sprue]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 792: | Line 883: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Crohns disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 818: | Line 909: | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Ulcerative colitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 852: | Line 943: | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Cystic fibrosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 878: | Line 969: | ||
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | * Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[VIPoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 911: | Line 1,002: | ||
* Followed by imaging | * Followed by imaging | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Zollinger-Ellison syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 933: | Line 1,024: | ||
* Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL | * Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Eosinophilic gastroenteritis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 958: | Line 1,049: | ||
* [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | * [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Primary bile acid malabsorption]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 980: | Line 1,071: | ||
* Positive [[SeHCAT]] | * Positive [[SeHCAT]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Abetalipoproteinemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,007: | Line 1,098: | ||
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level | * Clinical findings and low [[triglyceride]] and [[cholesterol]] level | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Microscopic colitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 1,038: | Line 1,129: | ||
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Hyperthyroidism]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,068: | Line 1,159: | ||
* [[TSH]] | * [[TSH]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Lactose intolerance]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,095: | Line 1,186: | ||
* [[Lactase]] activity assay | * [[Lactase]] activity assay | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Irritable bowel syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,115: | Line 1,206: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Chronic pancreatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,142: | Line 1,233: | ||
* [[Endoscopic retrograde cholangiopancreatography|ERCP]] | * [[Endoscopic retrograde cholangiopancreatography|ERCP]] | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,173: | Line 1,264: | ||
* Liver biopsy | * Liver biopsy | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Short bowel syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,204: | Line 1,295: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Small bowel bacterial overgrowth syndrome|Small bowel bacterial overgrowth]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,234: | Line 1,325: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" | '''[[X-linked agammaglobulinemia]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,259: | Line 1,350: | ||
* Low circulating immunoglobulin levels (IgG, IgA, IgM, IgE) on blood tests | * Low circulating immunoglobulin levels (IgG, IgA, IgM, IgE) on blood tests | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |Intestinal [[lymphangiectasia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 1,285: | Line 1,376: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Intestinal biopsy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Intestinal biopsy | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Amyloidosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 1,301: | Line 1,392: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Mastocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 1,317: | Line 1,408: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |Drug induced [[enteritis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 1,333: | Line 1,424: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Giardiasis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 1,349: | Line 1,440: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Strongyloidiasis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 1,365: | Line 1,456: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | ! style="background:#DCDCDC;" align="center" |[[Tuberculosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | |
Revision as of 16:25, 4 December 2017
Malabsorption
Abbreviations: WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A
Cause | Clinical manifestation | Lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | ||||||||||||||||
Duration | Diarrhea | Fever | Abdominal pain | Weight loss | |||||||||||||
Acute | Chronic | Watery | Bloody | Fatty | WBC | Hgb | Plt | S/E | Other lab findings | ||||||||
Whipple's disease | + | - | + | ± | + | + |
|
↓ | ↓ | ↓/↑ |
| ||||||
Celiac disease | ± | - | ± | - | + | + | - | ↓ | - |
|
|
|
|||||
Tropical sprue | + | - | + | + | + | + |
|
- | ↓ | - |
|
| |||||
Crohns disease | + | + | + | + | + | + | ↑ | ↓ | ↑ |
|
|
|
| ||||
Ulcerative colitis | + | + | + | + | + | + |
|
↑ | ↓ | ↑ |
|
|
|
| |||
Cystic fibrosis | - | - | + | ± | + | + |
|
- | ↓ | - |
|
|
| ||||
VIPoma | + | - | + | - | + | + | - | - | - |
|
|
| |||||
Zollinger-Ellison syndrome | + | - | + | - | + | + | - | ↓ | - |
|
| ||||||
Eosinophilic gastroenteritis | + | - | + | - | + | + | ↑ | - | - |
|
|
|
| ||||
Primary bile acid malabsorption | + | - | + | - | + | + | - | ↓ | - |
|
|
| |||||
Abetalipoproteinemia | + | - | + | - | + | + | - | - | - |
|
|
|
| ||||
Microscopic colitis | + | + | - | - | + | + | - | ↓ | - |
|
|
|
| ||||
Hyperthyroidism | + | - | - | ± | + | + | - | - | - |
|
|||||||
Lactose intolerance | + | - | - | - | + | - | - | - | - |
|
|
| |||||
Irritable bowel syndrome | ± | - | ± | - | ± | - |
|
- | - | - |
| ||||||
Chronic pancreatitis | + | - | + | - | + | + |
| ||||||||||
Cirrhosis | + | - | + | + | + | + | |||||||||||
Short bowel syndrome | - | ||||||||||||||||
Intestinal lymphoma | |||||||||||||||||
Agammaglobulinemia | |||||||||||||||||
Intestinal lymphangiectasia | |||||||||||||||||
Amyloidosis | |||||||||||||||||
Mastocytosis | |||||||||||||||||
Small intestinal bacterial overgrowth | |||||||||||||||||
Drug induced enteritis | |||||||||||||||||
HIV infection | |||||||||||||||||
Giardiasis | |||||||||||||||||
Strongyloidiasis | |||||||||||||||||
Tuberculosis |
Chronic diarrhea
Abbreviations: WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A
Cause | Clinical manifestation | Lab findings | Additional findings | Cause/Pathogenesis | Gold standard diagnosis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | |||||||||||||
Diarrhea | Fever | Abdominal pain | Weight loss | |||||||||||
Watery | Bloody | Fatty | WBC | Hgb | Plt | Other lab findings | ||||||||
Whipple's disease | + | - | + | ± | + | + |
|
↓ | ↓ | ↓/↑ |
| |||
Celiac disease | ± | - | ± | - | + | + | - | ↓ | - |
|
|
|
||
Tropical sprue | + | - | + | + | + | + |
|
- | ↓ | - |
|
| ||
Crohns disease | + | + | + | + | + | + | ↑ | ↓ | ↑ |
|
|
|
| |
Ulcerative colitis | + | + | + | + | + | + |
|
↑ | ↓ | ↑ |
|
|
|
|
Cystic fibrosis | - | - | + | ± | + | + |
|
- | ↓ | - |
|
|
| |
VIPoma | + | - | + | - | + | + | - | - | - |
|
|
| ||
Zollinger-Ellison syndrome | + | - | + | - | + | + | - | ↓ | - |
|
| |||
Eosinophilic gastroenteritis | + | - | + | - | + | + | ↑ | - | - |
|
|
|
| |
Primary bile acid malabsorption | + | - | + | - | + | + | - | ↓ | - |
|
|
| ||
Abetalipoproteinemia | + | - | + | - | + | + | - | - | - |
|
|
|
| |
Microscopic colitis | + | + | - | - | + | + | - | ↓ | - |
|
|
|
| |
Hyperthyroidism | + | - | - | ± | + | + | - | - | - |
|
||||
Lactose intolerance | + | - | - | - | + | - | - | - | - |
|
|
| ||
Irritable bowel syndrome | ± | - | ± | - | ± | - |
|
- | - | - |
| |||
Chronic pancreatitis | + | - | + | - | + | + | - | - | - |
|
|
|||
Cirrhosis | + | - | + | + | + | + |
|
↓ | ↓ | ↓ |
|
|
|
|
Short bowel syndrome | + | - | + | - | - | + |
|
- | ↓ | ↑ |
|
|
|
|
Small bowel bacterial overgrowth | + | - | + | - | + | + | - | ↓ | - |
|
|
| ||
X-linked agammaglobulinemia | + | - | + | + | + | + |
|
↓ | ↓ | - |
|
|
|
|
Intestinal lymphangiectasia | - | - | + | - | - | + |
|
↓ | - | - |
|
|
|
Intestinal biopsy |
Amyloidosis | + | |||||||||||||
Mastocytosis | ||||||||||||||
Drug induced enteritis | ||||||||||||||
Giardiasis | + | |||||||||||||
Strongyloidiasis | ||||||||||||||
Tuberculosis | ||||||||||||||
Chronic laxative abuse |